Translational Research Program

Funding Agency:
Leukemia & Lymphoma Society

Since 1995, the TRP grants fund new and innovative research that shows high promise of moving from laboratory discoveries to clinical application.

The goal of this translational award is to reduce the time between laboratory findings and actual treatment, putting research on the bench-to-bedside fast track when it comes to finding better treatment and cures for blood cancers.


Letter of Intent Due October 28, 2022, 3:00 PM ET
Full Application Due January 17, 2023, 3:00 PM ET


Agency Website

Eligibility Requirements

Applicants must hold an M.D., Ph.D., or equivalent degree, and work in domestic or foreign non-profit organizations, such as universities, colleges, hospitals or laboratories. Applications may involve multiple such institutions and the Applicant should have an independent research or academic position. Applicants need not be U.S. citizens, and there are no restrictions on Applicant age, race, gender or creed. 

Applications from non-academic facilities, post doctoral positions and the National Institutes of Health are not eligible

Amount Description

Limited to a maximum of $200,000.00 annually, which includes direct costs and a maximum overhead of $19,982.00 or 11.1 percent of direct costs per year for three years. Budget requests must be carefully justified and commensurate with the project's needs.

Funding Type



Junior Faculty
Medical Fellow/Resident
Post Doctoral Fellows


Medical - Translational

External Deadline

October 28, 2022